• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


litigation

  1. Litigation - Pre call planning Veeva notes

    I can't wait to begin writing PRE CALL PLANNING notes in Veeva.:cool: I will make sure that the pre-call planning notes are VERY detailed. I don't actually think anyone will read the notes (except for the litigation lawyers). I haven't had to write PRE CALL NOTES since the 80s. Do you think the...
    • anonymous
    • Thread
    • litigation wtf
    • Replies: 8
    • Forum: GlaxoSmithKline

  2. LITIGATION - Pre-call Planning

    I can't wait to begin writing PRE CALL PLANNING notes in Veeva. I will make sure that the pre-call planning notes are VERY detailed. I don't actually think anyone will read the notes (except for the litigation lawyers). I haven't had to write PRE CALL NOTES since the 80s. Do you think the...
    • anonymous
    • Thread
    • litigation wtf
    • Replies: 4
    • Forum: Syneos Health

  3. Allergan patent litigation

    Allergan reaches a settlement with Famy Care and it will grant Famy Care a license to market generic version of Restasis in U.S. in 2024.
    • anonymous
    • Thread
    • agreement allergan drugs litigation patent
    • Replies: 0
    • Forum: Allergan

  4. Cialis drug's "erectile dysfunction"

    Cialis, a drug that is used to treat impotence, was given for a free trial for the first time users in 2004. Now the patent for Cialis expires earlier than the previous date.
Top Bottom
Back